AXGN

AXGN

USD

Axogen Inc. Common Stock

$23.770+0.710 (3.079%)

リアルタイム価格

Healthcare
医療機器
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$23.060

高値

$23.830

安値

$22.920

出来高

0.27M

企業ファンダメンタルズ

時価総額

1.1B

業種

医療機器

United States

取引統計

平均出来高

1.10M

取引所

NCM

通貨

USD

52週レンジ

安値 $9.22現在値 $23.770高値 $23.83

関連ニュース

GlobeNewswire

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

もっと見る
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26

HC Wainwright & Co. analyst Yi Chen maintains Axogen with a Buy and raises the price target from $25 to $26.

もっと見る
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26
Analyst Upgrades

Raymond James Maintains Outperform on Axogen, Raises Price Target to $27

Raymond James analyst Jayson Bedford maintains Axogen with a Outperform and raises the price target from $20 to $27.

もっと見る
Raymond James Maintains Outperform on Axogen, Raises Price Target to $27
Analyst Upgrades

Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27

Canaccord Genuity analyst Caitlin Cronin maintains Axogen with a Buy and raises the price target from $24 to $27.

もっと見る
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27
Analyst Upgrades

Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34

Citizens analyst David Turkaly maintains Axogen with a Market Outperform and raises the price target from $26 to $34.

もっと見る
Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34
GlobeNewswire

Axogen, Inc. Reports Third Quarter 2025 Financial Results

ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

GlobeNewswire

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,